DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorLinkoeping University
About this trial
This randomized controlled trial will assess the impact of the FoodSwitch mobile app, which provides interpretive front-of-pack labelling via barcode scanning, in 900 Swedish adults with type 2 diabetes. Participants will be randomized to app + standard advice or standard advice alone. The primary outcome is change in HbA1c at 6 months; secondary outcomes include anthropometrics, quality of life, medication use, hospitalizations, and mortality.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
Self-reported type 2 diabetes with a duration of ≥2 years
Regularly grocery shopping
Disqualifiers
No access to BankID (a digital identification system commonly used in Sweden)
Failure to complete eligibility screening and run-in periods
Trial design
Treatments tested in this trial
- FoodSwitch
Treatment groups
900 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov